Ginsenoside-Rb1-mediated anti-angiogenesis via regulating PEDF and miR-33a through the activation of PPAR-γ pathway

Keyphrases

• 3′-untranslated Region (3′-UTR) 12%
• Angiogenesis 12%
• Anti-angiogenesis 100%
• Antiangiogenic Activity 25%
• Antiangiogenic Agents 25%
• Bioinformatic Prediction 12%
• Biological Processes 12%
• Ginsenoside 12%
• Ginsenoside Rb1 100%
• GW9662 12%
• Heart Tumor 12%
• Human Umbilical Vein Endothelial Cells (HUVECs) 37%
• In Vitro Assay 12%
• Ischemic Heart Disease 12%
• Luciferase Reporter Assay 12%
• MiR-33a 100%
• Molecular Mechanism 12%
• MRNA Level 12%
• New Blood Vessel 12%
• Overexpression 12%
• Panax Ginseng 12%
• Peroxisome Proliferator-activated Receptor 100%
• Peroxisome Proliferator-activated Receptor Signaling Pathway 12%
• Pigment Epithelium-derived Factor 100%
• Post-transcriptional Regulation 12%
• Pre-incubation 12%
• Pre-miR 12%
• Protein Expression 25%
• Quantitative PCR 12%
• Receptor Antagonist 12%
• Regress 12%
• Small Interfering RNA (siRNA) 12%
• Vasculature 12%

Immunology and Microbiology

• 3' Untranslated Region 25%
• Angiogenesis 25%
• Angiogenesis Inhibitor 50%
• Antiangiogenic Activity 100%
• Atherosclerosis 25%
• Bioinformatics 25%
• Biological Phenomena and Functions Concerning the Entire Organism 25%
• Blood Vessel 25%
• Genetic Transfection 25%
• Ginseng 25%
• Peroxisome 100%
• Protein Expression 50%
• Real Time Polymerase Chain Reaction 25%
• Reporter Gene 25%
• Umbilical Vein Endothelial Cell 75%
• Upregulation 25%
• Vascularization 25%

Pharmacology, Toxicology and Pharmaceutical Science

• 2 Chloro 5 Nitrobenzanilide 33%
• Angiogenesis Inhibitor 66%
• Antiangiogenic 66%
• Atherosclerosis 33%
• Ginseng 33%
• Ginsenoside Rb 1 100%
• Ischemic Heart Disease 33%
• Luciferase 33%
• Malignant Neoplasm 33%
• Messenger RNA 66%
• Peroxisome Proliferator Activated Receptor 100%
• Peroxisome Proliferator Activated Receptor Antagonist 33%
• Small Interfering RNA 33%